Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at the order in which everolimus and sunitinib should be given for advanced kidney cancer (RECORD 3)

Overview

Cancer types:

Kidney cancer, Renal cell cancer

Status:

Results

Phase:

Phase 2

Details

This trial compared 2 different orders (sequences) of having everolimus and sunitinib for kidney cancer that had spread to other parts of the body. It was for people who had the most common type of kidney cancer called renal cell cancer.

Recruitment start: 5 May 2010

Recruitment end: 17 May 2011

How to join

Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Amit Bahl

Supported by

NIHR Clinical Research Network: Cancer

Novartis

Last reviewed: 25 May 2015

CRUK internal database number: 4214

Help and support